PUMA BIOTECHNOLOGY (PBYI) Directors Sell $612,000 in Stock on Same Day

Two Puma Biotechnology directors sold a combined 67,150 shares on 14 September at around $9.10 apiece, one of them right after exercising options.

Share
Puma Biotechnology develops targeted cancer therapies.

Two directors of Puma Biotechnology (PBYI) sold shares on the same day, according to Form 4 filings with the Securities and Exchange Commission. The open-market sales on 14 September came to roughly $612,494 in combined value, spread over 67,150 shares at prices of about $9.10 each.